Skip to NavigationSkip to content

Bernie Sanders

Lawsuit against FDA claims Bernie Sanders played role in approval of rival drug

Catalyst Pharmaceutical is attempting to show in court that pressure from US Senator Bernie Sanders led to the approval of a rival treatment.

In June 2019, Catalyst filed a lawsuit against the FDA over their decision to approve a rival treatment for Lambert-Eaton Myasthenic Syndrome (LEMS) by Jacobus Pharmaceuticals. Partially redacted emails from the FDA show that issues arose over the $375,000 list price for Catalysts Firdapse (amifampridine), which led Sanders to allege the company was price gouging.

How do the Presidential frontrunners plan to combat the opioid crisis?

Published on 12/02/20 at 12:58pm

The widespread addiction to extremely potent, legal painkillers has decimated the lives of millions across the United States. Overdoses from opioids have surpassed car crashes and gun violence as the leading cause of death in Americans under the age of 55. The epidemic has killed nearly 400,000 people since 2000 – more people than HIV at the peak of that disease – while its economic cost has been placed between $50 billion and $1 trillion.

Rochester Drug Cooperative ceases opioid sales following criminal charges

The Rochester Drug Cooperative (RDC) has announced it will no longer distribute opioid medications after two of its executives were charged with illegally distributing opioids and conspiring to defraud the FDA.

The RDC said in a statement that: "The ever-increasing expenses associated with the legal and regulatory compliance for this segment of drugs are simply not sustainable. While these specific drugs represent a relatively small percent of total sales, they account for significant legal and compliance."

Democrat Presidential Candidates pledge to lower drug prices without Congress’ help

Two Democratic presidential candidates said that if they are elected president they will act immediately to reduce the cost of certain drugs, with or without the help of Congress.

Both Senator Elizabeth Warren of Massachusetts and Senator Amy Klobuchar of Minnesota, said they would act independently of Congress and said that the powers of the presidency means they have the legal authority to rein in prices without Congressional action.

Pharmacies argue that prescribers bear ultimate responsibility for the opioid crisis

Pharmacy chains have argued in federal court that doctors and healthcare practitioners who write prescriptions bear ultimate responsibility for the improper distribution of opioids to patients, not the chains themselves.

The filings were submitted Monday to the federal judge in Cleveland, who has been overseeing national opioid lawsuits. It asked the judge to rule in their favour and reject the claims bought by Ohio county against them.

Pfizer, Sanofi and GlaxoSmithKline plan to increase US drug prices in 2020

Multiple drugmakers, including Pfizer, Sanofi and GlaxoSmithKline, plan to increase US list prices on more than 200 drugs in the United States.

Most price increases are expected to be announced later this week. Most will be below 10 percent and around half of them will be in the 4-6 percent range, as most drugmakers have pledged to keep their price increases below 10 percent a year due to pressure from patients and politicians.

Eli Lilly CEO says Elizabeth Warren’s claims they failed on cheaper insulin is 'nonsense'

David Ricks, the CEO of Eli Lilly, has said that Presidential candidate Senator Elizabeth Warren’s claims his company failed on its pledge to provide lower-priced insulin is “nonsense.”

Ricks said this, in an interview with CNBC, in response to a survey Warren released on Monday with Senator Richard Blumenthal.

Senators call on FDA to use "forceful response" against Novartis over faulty data scandal

Five senators, including presidential candidates Bernie Sanders and Elizabeth Warren, have condemned Novartis for using “falsified data… to obtain approval of its gene therapy, Zolgensma… the most expensive medication in American history.”

US presidential candidate Bernie Sanders pledges to allow Americans to import drugs from Canada

Democratic presidential candidate Bernie Sanders has said he will, on his first day in office, allow for the importation of prescription drugs from Canada to the United States.

“On day one of my administration, I will direct the Secretary of Health and Human Services and FDA Commissioner to allow pharmacists, wholesalers and patients to purchase FDA approved prescription drugs from Canada,” Sanders said.

“There is no rational reason why insulin and other life-saving medications should cost ten times more in the United States than Canada.”

Bernie Sanders calls on FDA to allow generic, low cost versions of Catalyst Pharma's $375,000 rare disease drug

US Senator Bernie Sanders has called on regulators to allow pharmacies and manufacturers to distribute generic versions of Catalyst Pharmaceuticals’ Firdapse, a drug used to treat the rare neuromuscular disease Lambert-Eaton Myasthenic Syndrome (LEMS).

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches